The DEA has arrested several executives associated with nutraceutical maker Hi-Tech Pharmaceuticals for a variety of offences relating to the distribution of adulterated generic drugs. To read the Department of Justice press release, click here.
We previously mentioned Hi-Tech in connection with a trade dress dispute here, and Hi-Tech’s suit against the FDA on ephedra here. Also worthy of note are FDA ephedra seizures from Hi-Tech Pharmaceuticals, discussed here.
To say things are not looking good for Hi-Tech would be an understatement.
US v. Hi-Tech, ND GA, 06 CR 382, Indictment.